Literature DB >> 14708893

Gene expression in HCV-associated hepatocellular carcinoma--upregulation of a gene encoding a protein related to the ubiquitin-conjugating enzyme.

Ghada M El-Nady1, Roger Ling, Tim J Harrison.   

Abstract

BACKGROUND/AIMS: To investigate gene expression in HCV-associated human hepatocellular carcinomas (HCC) by identifying up- and down-regulated genes.
METHODS: Differential display RT-PCR was used to compare levels of gene expression in tumorous and non-tumorous tissues from the same livers. Differential expression was confirmed using a ribonuclease protection assay (RPA). The relative expression levels of one candidate gene were studied in various normal tissues and malignant cell lines using a multiple tissue expression (MTE) array. Further characterisation of this gene was carried out using nucleotide sequence analysis programmes and Northern hybridisation.
RESULTS: Fifty-two differentially expressed cDNA fragments were identified and 29 were cloned, sequenced and compared with the nucleotide sequence database. RPA confirmed reproducibly that one particular cDNA was upregulated in the tumour cells. Analysis using the MTE array revealed that this selected candidate gene is expressed at high levels in various human tumour cell lines. The expression levels in HCV-associated HCC were higher than in other tumours. Investigation revealed that this novel gene lies on chromosome 17. The transcript is approximately 2.5 kb in size and encodes a protein similar to the ubiquitin-conjugating enzyme.
CONCLUSIONS: The ubiquitin system may be involved in HCV-related hepatocarcinogenesis and in the development of other cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708893     DOI: 10.1034/j.1478-3231.2003.00862.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

1.  Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.

Authors:  Hassan El-Garem; Ayman Ammer; Hany Shehab; Olfat Shaker; Mohammed Anwer; Wafaa El-Akel; Heba Omar
Journal:  World J Hepatol       Date:  2014-11-27

2.  Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux.

Authors:  Peng Cheng; Jun Gong; Tao Wang; Jie Chen; Gui-Sheng Liu; Ru Zhang
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

3.  Hepatocellular carcinoma in Egypt: a single center study over a decade.

Authors:  Abdel-Rahman el-Zayadi; Hanaa M Badran; Eman M F Barakat; Mohy el-Deen Attia; Sherine Shawky; Mostafa K Mohamed; Osaima Selim; Ahmed Saeid
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

4.  Liver Disease Outcomes after Sustained Virological Response in Patients with Chronic Hepatitis C Infection Treated with Generic Direct-Acting Antivirals.

Authors:  Ekram W Abd El-Wahab; Waleed M Abd Elgawad; Mohamed S Abdelaziz; Ashraf I Mikheal; Hanan Z Shatat
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 3.707

5.  Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective.

Authors:  Manar Mahmoud El-Tonsy; Hesham Mohammed Hussein; Thanaa El-Sayed Helal; Rania Ayman Tawfik; Khalid Mohamed Koriem; Hend Mohamed Hussein
Journal:  J Parasit Dis       Date:  2014-12-20

6.  Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.

Authors:  Nadia I Zakhary; Sherif M Khodeer; Hanan E Shafik; Camelia A Abdel Malak
Journal:  J Adv Res       Date:  2013-01-11       Impact factor: 10.479

7.  Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation.

Authors:  Areeg M Dabbish; Hana M Abdelzaher; Moustafa Abohawya; Samir Shamma; Yosra H Mahmoud; Amr Maged; Mohamed Manaa; Mohamed Hassany; Firas Kobeissy; Omid Bazgir; Hassan El-Fawal; Hassan M E Azzazy; Anwar Abdelnaser
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.